查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2020477

2026-2034年全球上游生物製程市場規模、佔有率、趨勢和成長分析報告

Global Upstream Bioprocessing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計上游生物製程市場將從 2025 年的 368.1 億美元成長到 2034 年的 1,251 億美元，2026 年至 2034 年的複合年成長率為 14.56%。

受生物製藥和生物製藥產量不斷成長的推動，全球上游生物製程市場正快速發展。上游生物製程是指生物製藥生產的早期階段，包括細胞培養開發、發酵和培養基製備。這些製程對於疫苗、單株抗體和其他生物製藥的生產至關重要。對生物製藥和生物相似藥日益成長的需求是市場擴張的主要驅動力。

生物製程設備和細胞培養技術的進步正進一步加速市場成長。一次性生物反應器、先進細胞培養基和自動化生物製程系統等創新技術正在提高效率並降低生產成本。此外，製藥公司正大力投資研發，以開發治療各種疾病的新型生物製藥。

隨著生物製藥產業的持續擴張，上游工程生物製程市場預計將顯著成長。慢性病盛行率的上升和對標靶治療需求的不斷成長正在推動創新生物製藥的研發。生物製程技術的不斷改進和生物製造能力的提升將進一步支撐市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球上游生物製程市場：依產品分類

  • 市場分析、洞察與預測
  • 生物反應器/發酵罐
  • 細胞培養產品
  • 篩選
  • 生物反應器配件
  • 袋子和容器
  • 其他

第5章 全球上游生物製程市場：依工作流程分類

  • 市場分析、洞察與預測
  • 培養基製備
  • 細胞培養
  • 細胞分離

第6章 全球上游生物製程市場：依應用領域分類

  • 市場分析、洞察與預測
  • 多才多藝的
  • 一次使用

第7章 全球上游生物製程市場：按模式

  • 市場分析、洞察與預測
  • 內部
  • 外包

第8章 全球上游生物製程市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Merck KGaA
    • Corning Incorporated
    • Sartorius AG
    • Eppendorf AG
    • Danaher Corporation
    • Boehringer Ingelheim GmbH
    • Applikon Biotechnology BV
    • PBS Biotech Inc
    • Lonza Group Ltd
    • VWR International LLC
    • Meissner Filtration Products Inc
    • Repligen Corporation
    • Entegris Inc
    • Kuhner AG
簡介目錄
Product Code: VMR112114043

The Upstream Bioprocessing Market size is expected to reach USD 125.10 Billion in 2034 from USD 36.81 Billion (2025) growing at a CAGR of 14.56% during 2026-2034.

The global upstream bioprocessing market is growing rapidly due to the increasing production of biopharmaceuticals and biologics. Upstream bioprocessing involves the early stages of biopharmaceutical manufacturing, including cell culture development, fermentation, and media preparation. These processes are essential for producing vaccines, monoclonal antibodies, and other biological products. The growing demand for biologics and biosimilars is a major factor driving market expansion.

Technological advancements in bioprocessing equipment and cell culture technologies are further accelerating market growth. Innovations such as single-use bioreactors, advanced cell culture media, and automated bioprocessing systems are improving efficiency and reducing production costs. Additionally, pharmaceutical companies are investing heavily in research and development to develop new biologic therapies for various diseases.

Looking ahead, the upstream bioprocessing market is expected to grow significantly as the biopharmaceutical industry continues to expand. The rising prevalence of chronic diseases and the increasing demand for targeted therapies are encouraging the development of innovative biologic drugs. Continuous improvements in bioprocessing technologies and expanding biomanufacturing capacities will further support the market's long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Bioreactors/Fermenters
  • Cell Culture Products
  • Filters
  • Bioreactors Accessories
  • Bags & Containers
  • Others

By Workflow

  • Media Preparation
  • Cell Culture
  • Cell Separation

By Use Type

  • Multi-use
  • Single-use

By Mode

  • In-house
  • Outsourced

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, Merck KGaA, Corning Incorporated, Sartorius AG, Eppendorf AG, Danaher Corporation, Boehringer Ingelheim GmbH, Applikon Biotechnology BV, PBS Biotech Inc, Lonza Group Ltd, VWR International LLC, Meissner Filtration Products Inc, Repligen Corporation, Entegris Inc, Kuhner AG
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL UPSTREAM BIOPROCESSING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Bioreactors/Fermenters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Cell Culture Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Filters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Bioreactors Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Bags & Containers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL UPSTREAM BIOPROCESSING MARKET: BY WORKFLOW 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Workflow
  • 5.2. Media Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cell Culture Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Cell Separation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL UPSTREAM BIOPROCESSING MARKET: BY USE TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Use Type
  • 6.2. Multi-use Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Single-use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL UPSTREAM BIOPROCESSING MARKET: BY MODE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Mode
  • 7.2. In-house Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Outsourced Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL UPSTREAM BIOPROCESSING MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Workflow
    • 8.2.3 By Use Type
    • 8.2.4 By Mode
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Workflow
    • 8.3.3 By Use Type
    • 8.3.4 By Mode
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Workflow
    • 8.4.3 By Use Type
    • 8.4.4 By Mode
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Workflow
    • 8.5.3 By Use Type
    • 8.5.4 By Mode
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Workflow
    • 8.6.3 By Use Type
    • 8.6.4 By Mode
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL UPSTREAM BIOPROCESSING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Merck KGaA
    • 10.2.3 Corning Incorporated
    • 10.2.4 Sartorius AG
    • 10.2.5 Eppendorf AG
    • 10.2.6 Danaher Corporation
    • 10.2.7 Boehringer Ingelheim GmbH
    • 10.2.8 Applikon Biotechnology B.V
    • 10.2.9 PBS Biotech Inc
    • 10.2.10 Lonza Group Ltd
    • 10.2.11 VWR International LLC
    • 10.2.12 Meissner Filtration Products Inc
    • 10.2.13 Repligen Corporation
    • 10.2.14 Entegris Inc
    • 10.2.15 Kuhner AG